{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:28:27Z","timestamp":1786483707201,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015974","name":"Istituto di Ricerche Farmacologiche Mario Negri - IRCCS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009882","name":"Lombardy Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejim.2026.106789","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:30:49Z","timestamp":1772022649000},"page":"106789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Trends in cardiac amyloidosis hospital admissions and associated mortality risk over 20 years: a population-based study using healthcare administrative databases"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2920-1669","authenticated-orcid":false,"given":"Luisa","family":"Ojeda-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-709X","authenticated-orcid":false,"given":"Claudio","family":"Cimminiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-0887","authenticated-orcid":false,"given":"Mauro","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Fortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Baviera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejim.2026.106789_bib0001","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"3S","key":"10.1016\/j.ejim.2026.106789_bib0002","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hfc.2024.09.003","article-title":"Cardiac amyloidosis: how its epidemiology is changing","volume":"20","author":"Panichella","year":"2024","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.ejim.2026.106789_bib0003","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: jacc state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2026.106789_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the united states","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejim.2026.106789_bib0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejim.2026.106789_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.07.022","article-title":"Cardiac amyloidosis: an underdiagnosed\/underappreciated disease","volume":"67","author":"Manolis","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.106789_bib0007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2023.03.063","article-title":"Prevalence of transthyretin-related amyloidosis in Tuscany: data from the regional population-based registry","volume":"382","author":"Cappelli","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2026.106789_bib0008","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2021.04.023","article-title":"Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a tertiary referral centre in tuscany","volume":"335","author":"Zampieri","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2026.106789_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131804","article-title":"Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the veneto region, Italy","volume":"400","author":"De Michieli","year":"2024","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2026.106789_bib0010","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaccao.2021.05.004","article-title":"Two decades of cardiac amyloidosis: a danish nationwide study","volume":"3","author":"Westin","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.ejim.2026.106789_bib0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00392-022-02114-y","article-title":"Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018","volume":"112","author":"Ney","year":"2023","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106789_bib0012","first-page":"237","article-title":"The incidence and prevalence of cardiac amyloidosis in a large community-based cohort in Alberta","volume":"28","author":"Sepehrvand","year":"2022","journal-title":"Can J Card Fail"},{"issue":"7","key":"10.1016\/j.ejim.2026.106789_bib0013","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2016.200","article-title":"Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans","volume":"19","author":"Buxbaum","year":"2017","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.ejim.2026.106789_bib0014","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"ATTR-ACT study investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2026.106789_bib0015","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to image cardiac amyloidosis: a practical approach","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"24","key":"10.1016\/j.ejim.2026.106789_bib0016","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejim.2026.106789_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101232","article-title":"Impact of the noninvasive diagnostic algorithm on clinical presentation and prognosis in cardiac amyloidosis","volume":"3","author":"Tini","year":"2024","journal-title":"JACC Adv"},{"issue":"2","key":"10.1016\/j.ejim.2026.106789_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/HCO.0000000000001198","article-title":"New therapies to treat cardiac amyloidosis","volume":"40","author":"Nguyen","year":"2025","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ejim.2026.106789_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108758","article-title":"Optimizing drug therapies in cardiac amyloidosis","volume":"265","author":"Younis","year":"2025","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ejim.2026.106789_bib0020","first-page":"178","article-title":"Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management","volume":"32","author":"Hassan","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.ejim.2026.106789_bib0021","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejim.2026.106789_bib0022","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.114.04858","article-title":"Generating evidence from computerized healthcare utilization databases","volume":"65","author":"Corrao","year":"2015","journal-title":"Hypertension"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:39:29Z","timestamp":1786480769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":22,"alternative-id":["S0953620526000944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106789","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in cardiac amyloidosis hospital admissions and associated mortality risk over 20 years: a population-based study using healthcare administrative databases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106789"}}